Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

45.55p
   
  • Change Today:
    -0.20p
  • 52 Week High: 49.55p
  • 52 Week Low: 29.35p
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 681,014
  • Market Cap: £246.23m
  • RiskGrade: 119
  • Beta: 0.95

Regulatory News

Block Listing Six Monthly Return 30-Dec-2024 17:21 RNS
Notification of Major Holdings 10-Oct-2024 18:11 RNS
Interim Results 30-Sep-2024 07:00 RNS
Notification of Half Year Results 12-Sep-2024 07:00 RNS
Result of AGM 29-Jul-2024 16:10 RNS
Half Year Trading Update 29-Jul-2024 07:00 RNS
Notification of Major Holdings 23-Jul-2024 18:22 RNS
Notification of Major Holdings 23-Jul-2024 18:18 RNS
Notification of Major Holdings 23-Jul-2024 18:17 RNS
Senior Management and Board Update 23-Jul-2024 07:00 RNS
Annual Report and Notice of AGM 03-Jul-2024 12:46 RNS
Block Listing Six Monthly Return 02-Jul-2024 11:00 RNS
Total Voting Rights 01-Jul-2024 18:06 RNS
Grant of Options 27-Jun-2024 09:05 RNS
Notification of Major Holdings 21-Jun-2024 12:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 45.55p
Change Today -0.20p
% Change -0.44 %
52 Week High 49.55p
52 Week Low 29.35p
Volume 681,014
Shares Issued 540.57m
Market Cap £246.23m
Beta 0.95
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.17% below the market average12.17% below the market average12.17% below the market average12.17% below the market average12.17% below the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Price Trend
48.60% above the market average48.60% above the market average48.60% above the market average48.60% above the market average48.60% above the market average
67.35% above the sector average67.35% above the sector average67.35% above the sector average67.35% above the sector average67.35% above the sector average
Income Not Available
Growth
38.67% below the market average38.67% below the market average38.67% below the market average38.67% below the market average38.67% below the market average
31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 02-Jan-2025

Time Volume / Share Price
15:46 259 @ 45.55p
15:46 2,000 @ 45.55p
15:39 12 @ 45.56p
15:23 3,250 @ 45.70p
15:06 2,641 @ 45.80p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page